2015 : 13 publications

  • A. Carrouée, E. Allard-Vannier, S. Même, F. Szeremeta, J.C. Beloeil, I. Chourpa

Sensitive Trimodal Magnetic Resonance Imaging-Surface-Enhanced Resonance Raman Scattering-Fluorescence Detection of Cancer Cells with Stable Magneto-Plasmonic Nanoprobes.
Anal Chem 2015, 87:11233–41. DOI: 10.1021/acs.analchem.5b02419 IF 5,6

  • J. Gautier, E. Allard-Vannier, J. Burlaud-Gaillard, J. Domenech, I. Chourpa

Efficacy and Hemotoxicity of Stealth Doxorubicin-Loaded Magnetic Nanovectors on Breast Cancer Xenografts.
J. Biomed. Nanotechnol. 2015, 11: 177-189. IF 7,6

  • S. David, H. Marchais, D. Bedin, I. Chourpa

Modelling the response surface to predict the hydrodynamic diameters of theranostic magnetic siRNA nanovectors.
Int. J. Pharm. 2015, 478 (1): 409–415. IF 3,8

  • E. Perillo, E. Allard-Vannier, A. Falanga, P. Stiuso, M.T. Vitiello, M. Galdiero, S. Galdiero, I. Chourpa

Quantitative and qualitative effect of gH625 on the nanoliposome-mediated delivery of mitoxantrone anticancer drug to HeLa cells.
Int J Pharm. 2015, 488(1-2): 59-66. IF 3,8

  • J. Gautier, E. Munnier, M. Soucé, I. Chourpa, L. Douziech Eyrolles

Analysis of doxorubicin distribution in MCF-7 cells treated with drug-loaded nanoparticles by combination of two fluorescence-based techniques, confocal spectral imaging and capillary electrophoresis.
Anal Bioanal Chem. 2015, 407(12):3425-35. IF 3,6

  • H.T.P. Nguyen, E. Munnier, M. Soucé, X. Perse, S. David, F. Bonnier, F. Vial, F. Yvergnaux, T. Perrier, S. Cohen-Jonathan, I. Chourpa

Novel alginate-based nanocarriers as a strategy to include high concentrations of hydrophobic compounds in hydrogels for topical application.
Nanotechnol. 2015, 26: 255101 (13pp). doi:10.1088/0957-4484/26/25/255101 IF 3,7

  • C. Esnault, J. Jaillet, N. Delorme, N. Bouchet, S. Renault, L. Douziech-Eyrolles, J.F. Pilard, C. Augé-Gouillou

Kinetic analysis of the interaction of Mos1 transposase with its inverted terminal repeats reveals new insight into the protein-DNA complex assembly.
ChemBioChem, 2015, 16: 140-148. IF 3,1

  • F. Bonnier, M.E. Keating, T.P. Wróbel, K. Majzner, M. Baranska, A. Garcia-Munoz, A. Blanco, H.J. Byrne

Cell viability assessment using the Alamar blue assay: A comparison of 2D and 3D cell culture models.
Toxicol. In Vitro 2015, 29(1): 124-31. IF 3,2

  • L.F. Carvalho, F. Bonnier, K. O'Callaghan, J. O'Sullivan, S. Flint, H.J. Byrne, F. Lyng

Raman micro-spectroscopy for rapid screening of oral squamous cell carcinoma.
Exp. Mol. Pathol. 2015, 98(3): 502-509. IF 2,9

  • M.E. Keating, H. Nawaz, F. Bonnier, H.J. Byrne

Multivariate statistical methodologies applied in biomedical Raman spectroscopy: assessing the validity of partial least squares regression using simulated model datasets.
Analyst 2015, 140(7): 2482-92. IF 3,9

  • Z. Farhane, F. Bonnier, A. Casey, H.J. Byrne

Raman micro spectroscopy for in vitro drug screening: subcellular localisation and interactions of Doxorubicin.
Analyst 2015, 140:4212-23. DOI: 10.1039/C5AN00256G

  • Z. Farhane, F. Bonnier., A. Casey, A. Maguire, L. O'Neill, H.J. Byrne

Cellular discrimination using in vitro Raman micro spectroscopy: the role of the nucleolus.
Analyst. 2015. 140(17):5908-5919 IF 3,9

  • F. Lyng, D. Traynor, I. Ramos, F. Bonnier, H.J. Byrne

Raman spectroscopy for screening and diagnosis of cervical cancer.
Anal. Bioanal. Chem. 2015, 407(27); 8279. IF 3,6

2014 : 9 publications

  • P. Šimáková, J. Gautier, M. Procházka, K. Hervé-Aubert, I. Chourpa

Polyethylene-glycol-Stabilized Ag Nanoparticles for Surface-Enhanced Raman Scattering Spectroscopy: Ag Surface Accessibility Studied Using Metalation of Free-Base Porphyrins.
J. Phys. Chem. C 2014, 118: 7690–7697. IF 4,8

  • F. Bonnier, F. Petitjean, M.J. Baker, H.J. Byrne

Improved protocols for vibrational spectroscopic analysis of body fluids.
J Biophotonics. 2014, 7(3-4):167-79. doi: 10.1002/jbio.201300130 IF 3,9

  • L.M. Fullwood, D. Griffiths, K. Ashton, T. Dawson, R.W. Lea, C. Davis, F. Bonnier, H.J. Byrne, M.J. Baker

Effect of substrate choice and tissue type on tissue preparation for spectral histopathology by Raman microspectroscopy.
Analyst 2014,139: 446-54. IF 3,9

  • L.M. Fullwood, G. Clemens, D. Griffiths, K. Ashton, T. Dawson, R.W. Lea, C. Davis, F. Bonnier, H.J. Byrne, M.J. Baker

Investigating the use of Raman and Immersion Raman Spectroscopy for Spectral Histopathology of Metastatic Brain Cancer and Primary Sites of Origin.
Anal. Methods 2014, 6: 3948-3961. IF 1,9

  • F. Bonnier., M.J. Baker, H.J. Byrne

Vibrational spectroscopic analysis of body fluids: avoiding molecular contamination using centrifugal filtration.
Anal. Methods 2014, 6: 5155. IF 1,9

  • A. Tfayli, F. Bonnier, Z. Farhane, D. Libong, H.J. Byrne, A. Baillet-Guffroy

Comparison of structure and organization of cutaneous lipids in a reconstructed skin model and human skin: spectroscopic imaging and chromatographic profiling.
Exp Dermatol. 2014, 23: 441-3. IF 4,1

  • N. Rashid, H. Nawaz, K.W. Poon, F. Bonnier, S. Bakhiet, C. Martin, J.J. O'Leary, H.J. Byrne, F.M. Lyng

Raman microspectroscopy for the early detection of pre-malignant changes in cervical tissue.
Exp. Mol. Pathol. 2014, 97: 554-564. IF 2,9

  • F. Tian, F. Bonnier, A. Casey, A.E. Shanahan, H.J. Byrne

Surface enhanced Raman scattering with gold nanoparticles: effect of particle shape.
Anal. Methods 2014, 6: 9116. IF 1,9

  • F. Bonnier, D. Traynor, P. Kearney, C. Clarke, P. Knief, C. Martin, J.J. O'Leary, H.J. Byrne, F. Lyng

Processing ThinPrep cervical cytological samples for Raman spectroscopic analysis.
Anal. Methods 2014, 6: 7831-7841. IF 1,9